JOHNSON & JOHNSON Pre-tax Income 2007-2026 | JNJ
Beta
What is JOHNSON & JOHNSON's current pre-tax income?
JOHNSON & JOHNSON (JNJ) annual pre-tax income for 2025 was $32.58B, a 95.25% increase from 2024. JOHNSON & JOHNSON pre-tax income for the quarter ending March 29, 2026 was $5.99B.
What was JOHNSON & JOHNSON's pre-tax income in 2024?
JOHNSON & JOHNSON annual pre-tax income for 2024 was $16.69B, a 10.79% increase from 2023.
What was JOHNSON & JOHNSON's pre-tax income in 2023?
JOHNSON & JOHNSON annual pre-tax income for 2023 was $15.06B, a 21.46% decline from 2022.
What is JOHNSON & JOHNSON's 4-year pre-tax income CAGR?
JOHNSON & JOHNSON pre-tax income grew at a compound annual growth rate (CAGR) of 18.55% from FY2021 to FY2025, going from $16.50B to $32.58B over 4 years.
Pre-tax Income History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+13.5%
FY2019
$17.33B
→
FY2025
$32.58B
07081011121314161718192122232425
5 years selected
Pre-tax Income History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $32.58B | +95.2% | 10-K |
| FY2024 | $16.69B | +10.8% | 10-K |
| FY2023 | $15.06B | -21.5% | 10-K |
| FY2022 | $19.18B | +16.3% | 10-K |
| FY2021 | $16.50B | -4.8% | 10-K |
| FY2019 | $17.33B | -3.7% | 10-K |
| FY2018 | $18.00B | +1.8% | 10-K |
| FY2017 | $17.67B | -7.9% | 10-K |
| FY2016 | $19.20B | -6.6% | 10-K |
| FY2014 | $20.56B | +32.9% | 10-K |
| FY2013 | $15.47B | +12.3% | 10-K |
| FY2012 | $13.78B | -18.7% | 10-K |
| FY2011 | $16.95B | +7.6% | 10-K |
| FY2010 | $15.76B | -6.9% | 10-K |
| FY2008 | $16.93B | +27.4% | 10-K |
| FY2007 | $13.28B | - | 10-K |
Company: JOHNSON & JOHNSONTicker: JNJSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →